AIM ImmunoTech Announces the Expansion of its Pancreatic Cancer Program to Include New Patients ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. AIM ImmunoTech Announces the Expansion of its Pancreatic Cancer Program to Include New Patients ... AIM ImmunoTech Inc.February 10, 2021 GMT OCALA, Fla., Feb. 10, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that the Dutch Health and Youth Care Inspectorate (IGJ) has approved treatment for six pancreatic cancer patients as part of a new, follow-up Early Access Program (EAP) at Erasmus Medical Center in the Netherlands. Subject to further authorization we plan to ...
Source: apnews.com